NO20003584L - FremgangsmÕte ved fremstilling av immunglobulinpreparater - Google Patents

FremgangsmÕte ved fremstilling av immunglobulinpreparater

Info

Publication number
NO20003584L
NO20003584L NO20003584A NO20003584A NO20003584L NO 20003584 L NO20003584 L NO 20003584L NO 20003584 A NO20003584 A NO 20003584A NO 20003584 A NO20003584 A NO 20003584A NO 20003584 L NO20003584 L NO 20003584L
Authority
NO
Norway
Prior art keywords
immunoglobulin
preparation
pathogens
biological material
containing biological
Prior art date
Application number
NO20003584A
Other languages
English (en)
Other versions
NO20003584D0 (no
Inventor
Yendra Linnau
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3505143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003584(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20003584L publication Critical patent/NO20003584L/no
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO20003584D0 publication Critical patent/NO20003584D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Saccharide Compounds (AREA)
  • General Factory Administration (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Det er beskrevet en fremgangsmåte ved fremstilling av im- mulglobulin-preparater ved hvilken - et immunglobulinholdige biologiske materiale som innehol- der potensielle patogener, blandes med et organisk oppløs- ningsmiddel, - det med oppløsningsmiddel blandete immunglobulinholdige biologiske materiale bringes i kontakt med en ionebytter, idet de potensielt foreliggende patogener adsorberes til ionebyttermaterialet og de immunglobuliner som ikke eller bare ubetydelig inngår i en vekselvirkning med ionebytter- materialet, ikke blir bundet, og - ionebytteren med de potensielt adsorberte patogener skil- les fra det immunglobulinholdige biologiske materiale, hvorved det dannes et renset og virusfritt immungloburiri- preparat.
NO20003584A 1997-06-13 2000-07-12 FremgangsmÕte ved fremstilling av immunglobulinpreparater NO20003584D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0102997A AT407159B (de) 1997-06-13 1997-06-13 Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material
PCT/AT1998/000143 WO1998057672A2 (de) 1997-06-13 1998-06-10 Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material

Publications (2)

Publication Number Publication Date
NO20003584L true NO20003584L (no) 2000-02-10
NO20003584D0 NO20003584D0 (no) 2000-07-12

Family

ID=3505143

Family Applications (2)

Application Number Title Priority Date Filing Date
NO996118A NO996118L (no) 1997-06-13 1999-12-10 Fremgangsmåte ved fjerning av virale og molekylaere patogener fra et biologisk materiale
NO20003584A NO20003584D0 (no) 1997-06-13 2000-07-12 FremgangsmÕte ved fremstilling av immunglobulinpreparater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO996118A NO996118L (no) 1997-06-13 1999-12-10 Fremgangsmåte ved fjerning av virale og molekylaere patogener fra et biologisk materiale

Country Status (16)

Country Link
EP (2) EP0988063B2 (no)
JP (1) JP2002505674A (no)
AT (3) AT407159B (no)
AU (1) AU726808B2 (no)
BR (1) BR9810098A (no)
CA (1) CA2293401C (no)
CZ (1) CZ451699A3 (no)
DE (1) DE59805324D1 (no)
DK (1) DK0988063T4 (no)
ES (1) ES2181227T5 (no)
HU (1) HUP0003610A3 (no)
NO (2) NO996118L (no)
PT (1) PT988063E (no)
SI (1) SI0988063T1 (no)
SK (2) SK174799A3 (no)
WO (1) WO1998057672A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000074733A1 (en) * 1999-06-08 2000-12-14 Octapharma Ag Process for removing viruses from biological samples
AU2003241596B2 (en) * 2002-05-23 2010-01-21 Kedrion Melville Inc. Capture, concentration and quantitation of abnormal prior protein from biological fluids using depth filtration
AU2004294403A1 (en) * 2003-12-01 2005-06-16 Novo Nordisk Health Care Ag Nanofiltration of factor VII solutions to remove virus
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
CA2675039A1 (en) * 2007-01-12 2008-07-17 Alicon Ag Method for removing prion protein
EP2249661B1 (en) 2008-01-22 2018-05-16 Multimerics APS Products and methods to prevent infection
DE102021101099A1 (de) 2020-03-24 2021-09-30 Mecadi GmbH - Chemicals/ Processing Verwendung und Verfahren zur Reduktion der Virus-, Bakterien- und/oder Pilzsporenbelastung oder anderen biologischen Kontaminationen in Gasen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) † 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4590002A (en) * 1984-12-10 1986-05-20 Ortho Diagnostic Systems, Inc. Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
ATE85221T1 (de) † 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen

Also Published As

Publication number Publication date
EP1004323A1 (de) 2000-05-31
EP0988063B2 (de) 2010-08-11
WO1998057672A2 (de) 1998-12-23
PT988063E (pt) 2002-12-31
AT407159B (de) 2001-01-25
ATA102997A (de) 2000-05-15
HUP0003610A3 (en) 2002-09-30
ES2181227T5 (es) 2011-01-12
DK0988063T3 (da) 2002-12-16
SK175299A3 (en) 2000-07-11
EP0988063A2 (de) 2000-03-29
SI0988063T1 (en) 2002-12-31
DE59805324D1 (de) 2002-10-02
ATA95299A (de) 2000-10-15
DK0988063T4 (da) 2010-12-06
AU726808B2 (en) 2000-11-23
JP2002505674A (ja) 2002-02-19
SK174799A3 (en) 2000-07-11
CZ451699A3 (cs) 2000-05-17
NO20003584D0 (no) 2000-07-12
WO1998057672A3 (de) 1999-03-18
EP0988063B1 (de) 2002-08-28
HUP0003610A1 (hu) 2001-02-28
NO996118D0 (no) 1999-12-10
CA2293401A1 (en) 1998-12-23
AU7750098A (en) 1999-01-04
CA2293401C (en) 2005-11-08
NO996118L (no) 2000-02-10
AT407744B (de) 2001-05-25
ATE222778T1 (de) 2002-09-15
ES2181227T3 (es) 2003-02-16
BR9810098A (pt) 2000-08-08

Similar Documents

Publication Publication Date Title
Sternberger et al. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.
DK1156049T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
AU582970B2 (en) Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
NO20005295L (no) Effektiv rensing av adenovirus
NO20003584L (no) FremgangsmÕte ved fremstilling av immunglobulinpreparater
BR9808079A (pt) Uso de ressonância nuclear magnética unidimensional para identificar ligantes para biomoléculas alvos
FI953467A7 (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja men etelmä niiden valmistamiseksi
GR3032843T3 (en) Methods and compositions for detecting binding of ligand pair using non-fluorescent label
FI956078A7 (fi) Järjestelmä veren virusten inaktivoimiseksi
FI960123A7 (fi) Uudet alkyloidut (hetero)sykliset yhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
AU6067896A (en) Immunoglobulin for treatment of respiratory syncytial virus
ATE233784T1 (de) Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
CA2383554A1 (en) Methods for the detection, analysis and isolation of nascent proteins
DK44686D0 (da) Fremgangsmaade til oprensning af proteiner
SE8902919L (sv) Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer
Detzner et al. Thin-layer chromatography in structure and recognition studies of Shiga toxin glycosphingolipid receptors
ES2133743T3 (es) Material cromatografico.
NO933558D0 (no) Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
Hummert et al. Analytical techniques for monitoring harmful cyanobacteria in lakes
DK161045C (da) Kemisk forbindelse, deres anvendelse ved en immunokemisk analysemetode, og forbindelse til fremstilling af den kemiske forbindelse
Chen et al. Rearrangement of P‐N to P‐O bonds in mass spectra of N‐diisopropyloxyphosphoryl amino acids/alcohols
DK0824515T3 (da) Substitueret phenylamidiner, medikamenter indeholdende disse forbindelser og fremgangsmåder til fremstilling deraf
Smith et al. Use of paper partition and thin-layer chromatography for identification of active ingredient in Dursban insecticide and its possible metabolites
MY116425A (en) Process for the protection of a person against contamination as a result of improper, i.e. oral, application of toxic components of a transdermal therapeutic system, as well as transdermal therapeuticsystems containing a denaturant
Takeda et al. Purification of low-molecular-weight GTP-binding proteins structurally related to MTG33, a mitochondrial GTP-binding protein of Ehrlich ascites tumor cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application